<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

6 min read

EWMA 2020 Virtual Meeting Highlights and The Impact of COVID-19 on Wound Care

By Lennart Stadler on 1/18/21 11:46 AM

SmartTRAK reviews the 2020 Virtual EWMA meeting covering the impact of COVID-19, the growing use of digital tools and emerging technologies 

For the first time, the European Wound Management Association (EWMA) annual meeting, held November 18 – 19th 2020, was an all-virtual event. As the premier wound care conference in Europe, EWMA 2020 showcased the latest news and trends in the market for European Advanced Wound Dressings, which is projected to reach $1.8B in 2020 according to SmartTRAK estimates. It turned into a truly global event thanks to the format that welcomed 9,758 registered participants from 113 countries from all over the world.

Topics: Wound Care
Continue Reading
9 min read

Europe: New Routines in Greetings and in Wound Management

By Anikó Szekér on 12/21/20 10:21 AM

SmartTRAK examines the Top 5 countries in Europe during the time of COVID-19 and estimates how the Advanced Wound Dressing Market will be impacted in 2020 and 2021.

Using an elbow bump instead of a handshake or hug is not the only new routine people have learned during the pandemic. As winter arrives with an expected surge in COVID-19, healthcare systems and services in Europe are building on lessons learned from the spring outbreak to help shape the way health services will be delivered in the coming months.

Amid this pandemic, several factors are affecting growth in the European Advanced Dressings Market, which is projected to reach ~$2.07B (€1.85B) by 2024 according to SmartTRAK estimates. In this article, SmartTRAK reviews how the COVID-19 pandemic has evolved in Europe and how it is impacting the market for Advanced Dressings in France, Germany, the UK, Spain and Italy.

Continue Reading
2 min read

Gain vs Loss: Q320 Infection Prevention: US Vascular Access Adjunct Market

By Susan Paquette on 12/18/20 10:44 AM

Q3 makes a recovery from Q220 losses but gains remain below pre-COVID levels

For Q320, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention-Vascular Access Adjunct Products market was down -1.8% YoY. Leading manufacturers in this segment hit hard in Q220 by COVID-19 restrictions and elective procedure cancellations reported positive growth over Q2, but are still not at pre-COVID-19 levels.

Among the many topics, including company revenues, shares, charts and expert analysis, covered in the comprehensive Q320 Infection Prevention: US Vascular Access Adjunct Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

Bouncing Back: Q320 Advanced Wound Care (AWC) Market Recap

By Susan Paquette on 12/16/20 9:30 AM

In Q320, Advanced Wound Care bounced back to almost normal levels amidst the COVID-19 pandemic with patients returning for chronic wound treatment.

For Q320, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics increased slightly YoY.

3M* remained the WW market leader, up +1.5% YoY, driven by tentative signs of improvement in elective procedures. WW Advanced Dressings returned to positive growth, with mixed performance among leading players. US Skin/Dermal Substitute (CTP) revenue rebounded over Q319, driven by a whopping performance by Organogenesis, while WW NPWT was down slightly YoY, with single-use down and traditional devices flat.

Among the many topics covered in the comprehensive Q320 Advanced Wound Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

A Journey Back to Normalcy: Q320 Hemostats and Sealants Market Recap

By Doug Devens on 12/7/20 9:58 AM

The US market for Hemostats and Sealants began the journey back to normalcy, slipping -0.2% YoY in Q320, as elective surgeries began to be performed again. Hemostats led the charge with Sealants not far behind.

As the US healthcare system begins to manage COVID-19 and elective procedures return toward pre-COVID-19 levels, the US Hemostats and Sealants market rebounded with a drop of only -0.2% YoY in Q320 according to SmartTRAK Financial Dashboard. Most manufacturers still experienced declines in Q320, but far narrower than the losses of Q220. Ethicon* managed a +4.5% gain in Q320 while the other manufacturers essentially treaded water with respect to Q319.

Among the many topics covered in the comprehensive Q320 US Hemostats and Sealants Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

Rebounding to Pre-COVID Levels: Q320 US Surgical Matrices Market Recap

By Doug Devens on 12/3/20 3:26 PM

The US Surgical Matrices Market rebounded toward pre-COVID-19 levels in Q320 as the numbers of hernia and breast surgeries came closer to normal levels. The recovery was somewhat uneven, with Breast Matrices still off -8.6% YoY, while Hernia Matrices were closer to pre-COVID-19 levels, off -2.5% YoY.

As hospitals began to establish a new normal in the time of COVID-19, the US Surgical Matrices Market rebounded to lose only -4.6% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie* (formerly Allergan) held on to its lead despite the effects of the pandemic, as its breast-heavy portfolio showed a slower return to normal. Becton Dickinson* (BD) lost less than AbbVie/Allergan, declining –3.5% YoY, as hernia procedures bounced back to normal levels a little faster.

Among the many topics covered in the comprehensive Q320 US Surgical Matrices Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

Unwrapping the Market for Adjustable Compression Wraps

By Terry Hayslett on 11/16/20 11:41 AM

In recent years, leading manufacturers of static compression devices have expanded their product portfolios by investing in adjustable compression wraps (ACWs). A quick search in SmartTRAK shows that in 2014, Lohmann & Rauscher* acquired Solaris and added ReadyWrap*and TributeWrap brands to its portfolio. In 2016, Sigvaris* acquired Biacare, a US-based company with a strong reputation as a leader in the design and production of medical short-stretch wraps. Sigvaris now promotes and offers a range of compression wraps, including CompreFlex*and CoolFlex*. In 2019, medi* USA announced the launch of its new ready-to-wear circaid juxtalite hd inelastic compression wrap, and in 2020 Juzo*added a new compression wrap that has a slip-on feature and a new patent-pending inner connector.

Given the attention and investment dollars allocated to ACWs in recent years, this article explores the ACW market to provide greater visibility into key market dynamics, underlying value drivers and the outlook for future growth.

It is estimated that over 200 million people worldwide (WW) have venous and/or lymphatic conditions that are treatable with compression therapy. Some of the more common conditions include chronic edema, varicose veins, venous leg ulcers (VLUs), lymphedema and deep vein thrombosis. SmartTRAK estimates that ...

To download and read the complete Adjustable Compression Wraps Market Outlook article, please click the button below.

Download the ACW Market Outlook Article

Topics: Wound Care
Continue Reading
10 min read

Skin Substitutes (CTPs) Continue to Push Boundaries in Advanced Wound Care

By Susan Paquette on 10/19/20 3:28 PM

Despite the uncertainty of COVID-19, Skin Substitutes (CTPs) continue to push the boundaries in Advanced Wound Care with impressive clinical studies, new products and technologies, and changing market dynamics.

Despite the unpredictability of COVID-19, skin substitutes (CTPs – cellular and/or tissue-based products) continue to be a hot area of research, innovation and investment in the market for Advanced Wound Care (AWC). This segment is comprised of an assortment of products, including human dermal allografts, amniotic tissue allografts, xenografts, cell-based bioengineered and most recently synthetic type products. Wounds most often treated with these products include diabetic foot ulcers, venous leg ulcers, pressure ulcers, challenging surgical wounds, trauma wounds and burns. In addition, these wounds are treated in a variety of settings that include the hospital outpatient department (HOPD) wound clinic, physician office, surgical suite and burn center. In the following article, SmartTRAK reviews the latest news on skin substitutes (CTPs) from SAWC Spring 2020 and provides an update on investment activities as well as reimbursement and market trends amid COVID-19.

Topics: Wound Care
Continue Reading
1 min read

A Downward Slide: Q220 Infection Prevention Vascular Access Recap

By Susan Paquette on 9/30/20 9:54 AM

Q220 reflects the full impact of COVID-19, driving a downward slide in all segments

For Q220, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market was down -16.8% YoY.

The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

Among the many topics covered in the comprehensive  Q220 Infection Prevention: US Vascular Access Adjunct Market Recap* are:
Continue Reading
2 min read

Major Shrinkage: Q220 Advanced Wound Care Market Recap

By Susan Paquette on 9/23/20 9:00 AM

In Q220, all geographies experienced shrinkage in their AWC revenues with Single-use NPWT showing the sharpest declines.

All companies are experiencing a negative impact on their wound businesses from COVID-19 in Q220, but most are also stating that June was better than April, indicating a strong recovery in the wound market. 3M* remains the WW market leader with Q220 revenue down -14.9% YoY. WW Advanced Dressings declined -9.9%, impacted by COVID-19, especially in hospitals. US Skin/Dermal Substitute (CTP) revenue fell also, with mixed results from market leaders. WW NPWT was down -17.8%, with single-use and traditional devices down -24.2% and -16.4%, respectively.

Among the many topics covered in the comprehensive Q220 Advanced Wound Care Market Recap* are:

Continue Reading

    Recent Articles